Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

deltaDOT Announces Manufacturer for 1D Protein/Nucleic Acid Analysis System

Published: Thursday, September 08, 2005
Last Updated: Thursday, September 08, 2005
Bookmark and Share
The Peregrine Protein/Nucleic Acid analysis system and the Merlin DNA sequencer are designed to offer unrivalled sensitivity, ultra high-speed throughput and low running costs.

deltaDOT has announced that Lathrop Engineering has been awarded the manufacturing contract for its first two commercial products, a protein/nucleic acid analysis system and a DNA sequencer. These products are based on deltaDOT's proprietary Label Free Intrinsic Imaging (LFII) technology.

Both the Peregrine Protein/Nucleic Acid analysis system and the Merlin DNA sequencer are designed to offer unrivalled sensitivity, ultra high-speed throughput and low running costs.

Tony Baxter, CEO of deltaDOT said "We are very impressed with Lathrop's manufacturing capabilities and are confident in their ability to deliver high-quality systems with fast delivery times.”

He adds, “Having previously developed a range of biomedical products, including electrophoresis systems, Lathrop understands the stringent tolerances of this business and the requirements of manufacturing precision instrumentation.”

Further he said, “Their technical abilities, industry experience, and short development cycles are all advantages that we can pass on directly to our customers."

deltaDOT's biomolecule detection technique, LFII, is derived from recent innovations in high-energy physics research and their application in modern biochemical analysis.

Unlike conventional techniques, the technology does not require target molecules to be labelled and therefore enables superior data quantification, while reducing throughput times, operating costs and health and safety issues.

"Both the management and engineering teams at Lathrop are tremendously excited to be working with deltaDOT on the Peregrine and Merlin projects," said Bruce Richardson, VP of Engineering for Lathrop.
He adds, "Founded in their background and field knowledge, both in the bioscience and particle physics, deltaDOT has created a core set of technologies that offer immediately recognizable benefits.”

“The ability to detect and quantify unlabelled proteins is a significant accomplishment and immensely important to the research and pharmaceutical development communities.”

Further he said, “This will also provide deltaDOT with a substantial competitive advantage in the biomedical market and we look forward to sharing in their future success."

 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!